Corindus Vascular Robotics has announced the appointment of Jeff Lemaster as chief commercial officer.
Lemaster brings 20 years of commercial sales and marketing experience in the cardiovascular medical device industry to Corindus and has extensive global new product launch experience in the areas of interventional cardiology and peripheral. He most recently served as global vice president, Marketing of CR Bard. He has a proven track record of commercial success having held senior sales and marketing leadership positions at CR Bard, Acist Medical Systems and Boston Scientific.
As chief commercial officer at Corindus, Lemaster will lead and execute revenue and commercial strategy to drive growth and market adoption globally.
“I am delighted to welcome Jeff to Corindus, and we look forward to his future contributions. His extensive commercial experience, particularly in the interventional and peripheral arena, will enable us to build and sustain strong robotic programs that benefit our customers and their patients,” said Corindus CEO, Mark J Toland.
“I look forward to working with the Corindus team and the broader interventional community to build robotic programmes that transform the way we treat patients while protecting cath lab teams,” said Lemaster.
